Cabigas, Larissa Q.

HRN: 27-16-49  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/19/2025
AMPICILLIN 1GM (VIAL)
07/19/2025
07/20/2025
IVTT
2g
Q6h
PROM
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Intra-abdominalReproductive Tract    Compliance to guidelines: